Drug Shortage Report for TEVA-IRBESARTAN

Last updated on 2020-04-23 History
Report ID 94369
Drug Identification Number 02316404
Brand name TEVA-IRBESARTAN
Common or Proper name IRBESARTAN
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) IRBESARTAN
Strength(s) 150MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 100
ATC code C09CA
ATC description ANGIOTENSIN II ANTAGONISTS, PLAIN
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2019-09-18
Estimated end date 2020-11-30
Actual end date
Shortage status Actual shortage
Updated date 2020-04-23
Company comments Will continue to allocate until regular supply can be restored (TBA)
Health Canada comments
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v24 2020-04-23 French Compare
v23 2020-04-23 English Compare
v22 2020-04-09 French Compare
v21 2020-04-09 English Compare
v20 2020-04-02 French Compare
v19 2020-04-02 English Compare
v18 2020-02-13 French Compare
v17 2020-02-13 English Compare
v16 2020-01-24 French Compare
v15 2020-01-24 English Compare
v14 2019-12-19 French Compare
v13 2019-12-19 English Compare
v12 2019-12-05 French Compare
v11 2019-12-05 English Compare
v10 2019-11-28 French Compare
v9 2019-11-28 English Compare
v8 2019-10-24 French Compare
v7 2019-10-24 English Compare
v6 2019-10-17 French Compare
v5 2019-10-17 English Compare

Showing 1 to 20 of 24